anees

October 25, 2019

FDA Grants TauTona Group Orphan Drug Designation for Treatment of Sickle Cell Disease Ulcers

There is no standard of care for sickle cell patients who suffer from these debilitating wounds TauTona Group, a vertically-integrated operational venture fund focused on creating […]
Do you like it?
Read more